Improved survival after one course of perioperative chemotherapy in early breast cancer patients: long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854
- 31 December 2001
- journal article
- clinical trial
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 37 (17), 2184-2193
- https://doi.org/10.1016/s0959-8049(01)00294-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Disease-Free Survival Advantage of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Patients With Node-Negative, Rapidly Proliferating Breast Cancer: A Randomized Multicenter StudyJournal of Clinical Oncology, 2000
- Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast CancerJNCI Journal of the National Cancer Institute, 1998
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study.Journal of Clinical Oncology, 1994
- Prolonged Disease-Free Survival after One Course of Perioperative Adjuvant Chemotherapy for Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Is There a Role for Perioperative Adjuvant Cytotoxic Therapy in the Treatment of Early Breast Cancer?Published by Springer Science and Business Media LLC ,1989
- Perioperative Adjuvant Chemotherapy in Breast Cancer: The Scandinavian Adjuvant Chemotherapy Study 1Acta Oncologica, 1989
- Combination Adjuvant Chemotherapy for Node-Positive Breast CancerNew England Journal of Medicine, 1988
- Surgical adjuvant chemotherapy.Results with one short course with cyclophosphamide after mastectomy for breast cancerCancer, 1978
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958